scholarly journals Management Strategy and Surveillance of Intraductal Papillary Mucinous Neoplasm–Gastroenterologist’s Viewpoint

2021 ◽  
Vol 9 (1) ◽  
pp. 1-7
Author(s):  
Tae Hyeon Kim ◽  
Hyung Ku Chon
Keyword(s):  
Intraductal Papillary Mucinous Neoplasm ◽  
Management Strategy ◽  
Mucinous Neoplasm

SPYGLASS PANCREATOSCOPY FOR DIAGNOSIS, EVALUATION AND STAGING OF MAIN DUCT INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM

2019 ◽  
Author(s):  
R Morais ◽  
F Vilas-Boas ◽  
J Antunes ◽  
F Moreira ◽  
J Lopes ◽  
...  
Keyword(s):  
Intraductal Papillary Mucinous Neoplasm ◽  
Main Duct ◽  
Mucinous Neoplasm

Comparison of the diagnostic accuracy of EUS, MDCT, MRCP and ERCP in intraductal papillary mucinous neoplasm (IPMN) of the pancreas

Endoscopy ◽  
2006 ◽  
Vol 39 (S 1) ◽  
Author(s):  
H Imazu ◽  
Y Uchiyama ◽  
H Kakutani ◽  
K Goda ◽  
S Omar ◽  
...  
Keyword(s):  
Diagnostic Accuracy ◽  
Intraductal Papillary Mucinous Neoplasm ◽  
Mucinous Neoplasm

scholarly journals Should Contrast-Enhanced Harmonic Endoscopic Ultrasound Be Incorporated into the International Consensus Guidelines to Determine the Appropriate Treatment of Intraductal Papillary Mucinous Neoplasm?

2021 ◽  
Vol 10 (9) ◽  
pp. 1818
Author(s):  
Tomohiro Yamazaki ◽  
Mamoru Takenaka ◽  
Shunsuke Omoto ◽  
Tomoe Yoshikawa ◽  
Rei Ishikawa ◽  
...  
Keyword(s):  
Intraductal Papillary Mucinous Neoplasm ◽  
Predictive Value ◽  
Diagnostic Value ◽  
Consensus Guidelines ◽  
International Consensus ◽  
Mucinous Neoplasm ◽  
Appropriate Treatment ◽  
Contrast Enhanced ◽  
Diagnostic Values ◽  
International Consensus Guidelines

This study aimed to investigate whether the incorporation of contrast-enhanced harmonic endoscopic ultrasound (CH-EUS) into the international consensus guidelines (ICG) for the management of intraductal papillary mucinous neoplasm (IPMN) could improve its malignancy diagnostic value. In this single-center retrospective study, 109 patients diagnosed with IPMN who underwent preoperative CH-EUS between March 2010 and December 2018 were enrolled. We analyzed each malignancy diagnostic value (sensitivity (Se), specificity (Sp), positive predictive value (PPV), and negative predictive value (NPV)) by replacing fundamental B-mode EUS with CH-EUS as the recommended test for patients with worrisome features (WF) (the CH-EUS incorporation ICG) and comparing the results to those obtained using the 2017 ICG. The malignancy diagnostic values as per the 2017 ICG were 78.9%, 42.3%, 60.0%, and 64.7% for Se, Sp, PPV, and NPV, respectively. The CH-EUS incorporation ICG plan improved the malignancy diagnostic values (Se 78.9%/Sp, 53.8%/PPV, 65.2%/NPV 70.0%). CH-EUS may be useful in determining the appropriate treatment strategies for IPMN.

Sign in / Sign up

Export Citation Format

Share Document